Your browser doesn't support javascript.
loading
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis.
Molinelli, C; Jacobs, F; Agostinetto, E; Nader-Marta, G; Ceppi, M; Bruzzone, M; Blondeaux, E; Schettini, F; Prat, A; Viale, G; Del Mastro, L; Lambertini, M; de Azambuja, E.
Afiliação
  • Molinelli C; Academic Trials Promoting Team, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa. Electronic address: https://twitter.com/ChiaraMolinelli.
  • Jacobs F; Academic Trials Promoting Team, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium; Department of Biomedical Sciences, Humanitas University, Milan. Electronic address: https://twitter.com/FlaviaJacobs_.
  • Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: https://twitter.com/ElisaAgostinett.
  • Nader-Marta G; Academic Trials Promoting Team, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: https://twitter.com/Nader_Guilherme.
  • Ceppi M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Bruzzone M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Blondeaux E; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: https://twitter.com/BlondeauxEva.
  • Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona. Electronic addre
  • Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona; Reveal Genomics, Barcelona, Spain. Electronic address: https://twitter.com/prat_aleix.
  • Viale G; Department of Pathology, IEO European Institute of Oncology IRCCS, Milan.
  • Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: https://twitter.com/delmastro_lucia.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: https://twitter.com/matteolambe.
  • de Azambuja E; Academic Trials Promoting Team, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium; Medical Oncology Department, Institut Jules Bordet and l'Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: evandro.deazambuja@hubruxelles.be.
ESMO Open ; 8(4): 101592, 2023 08.
Article em En | MEDLINE | ID: mdl-37413762
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article